Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

January 15, 2022

Hydroxychloroquine May Slow PPMS Progression, Study Shows

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
  • MS Research Study and Reports
    /
 NOTE: Please always speak with your MS healthcare team before making any  decisions to try new treatments.   ——————————————— Oct 2021…
Alternative therapies and devices for Multiple Sclerosis (MS)

January 15, 2022

Evusheld for Pre-exposure Prevention of COVID-19 – This prevention medication is strictly for those who are not expected to have adequate immune responses to the vaccine

  • #COVID-19
    /
  • For the Benefit of the Patient
    /
  • Multiple Sclerosis
    /
 Last updated: December 17, 2021 The U.S. Food and Drug Administration (FDA) has authorized Evusheld (tixagevimab co-packaged with cilgavimab) as a…
#COVID-19

January 15, 2022

COVID-19 Studies Recruiting People with MS

  • #COVID-19
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  Overview The National MS Society is partnering with organizations and supporting research that seeks to understand the impacts of…
#COVID-19

January 14, 2022

Delaying b-cell depleters (Ocrevus, kesimpta, rituximab) increases the chance of getting protective antibodies after covid-19 vaccination

  • #COVID-19
    /
  • Multiple Sclerosis
    /
 January 13, 2022 Seroconversion following COVID-19 vaccination: Can we optimize protective response in CD20-treated individuals? Abstract Although there is an…
#COVID-19

January 14, 2022

COVID-19 Vaccine Response in People with Multiple Sclerosis

  • #COVID-19
    /
  • Multiple Sclerosis
    /
  Abstract Objective: The purpose of this study was to investigate the effect of disease modifying therapies on immune response to…
#COVID-19

January 14, 2022

Answering Viewers Questions: Highly Effective Multiple Sclerosis Medications

  • Boster's MS Corner
    /
  • MS Drug Therapies
    /
  Click to Subscribe for the MS Beacon eNewsletter and MS educational events Visit our MS Learning Channel on YouTube:…
Boster's MS Corner

January 14, 2022

Common Epstein-Barr Virus May Play Role in Debilitating Neurological Illness

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
 In a study of members of the Armed Forces, people who developed multiple sclerosis first had Epstein-Barr virus. A colored…
MS Research Study and Reports

January 11, 2022

Learning about MS Diagnosis & MS Symptoms, plus COVID updates – presented by Aaron Boster, MD

  • #COVID-19
    /
  • MS Educational Programs
    /
  • Multiple Sclerosis (MS) Symptoms
    /
  • Multiple Sclerosis Videos
    /
Watch Dr. Aaron Boster present                              …
#COVID-19

January 11, 2022

NMOSD PATIENTS MAY BE HIDDEN WITHIN THE MS POPULATION

  • NMO (NMOSD/Devics)
    /
  • Other Neuro Conditions
    /
 NMO vs MS – Click:  https://bit.ly/3tfnPZS An accurate diagnosis of NMOSD is critical, as patients with NMOSD have been misdiagnosed with MS1 Differential…
NMO (NMOSD/Devics)

January 11, 2022

Multiple Sclerosis, Lupus, Low-Dose Naltrexone, and the Hormone Connection

  • Multiple Sclerosis
    /
  • Other Neuro Conditions
    /
 #MS #LUPUS  #EPSTEINBARR According to the American Autoimmune Related Diseases Association (AARDA) about 50 million Americans have an autoimmune disease…
Multiple Sclerosis

Categories

Latest Blog Posts